BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 24182860)

  • 1. New developments in juvenile systemic and localized scleroderma.
    Foeldvari I
    Rheum Dis Clin North Am; 2013 Nov; 39(4):905-20. PubMed ID: 24182860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scleroderma in children.
    Zulian F
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):576-595. PubMed ID: 29773274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scleroderma in children: an update.
    Zulian F; Cuffaro G; Sperotto F
    Curr Opin Rheumatol; 2013 Sep; 25(5):643-50. PubMed ID: 23912318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty.
    Kim HS; Choi YJ; Park YM; Kim HO; Lee JY
    J Dermatol; 2011 Oct; 38(10):1024-7. PubMed ID: 21658114
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of severe or methotrexate-resistant juvenile localized scleroderma with mycophenolate mofetil.
    Martini G; Ramanan AV; Falcini F; Girschick H; Goldsmith DP; Zulian F
    Rheumatology (Oxford); 2009 Nov; 48(11):1410-3. PubMed ID: 19713439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleroderma "en coup de sabre" With Epilepsy and Uveitis Successfully Treated With Tocilizumab.
    Osminina M; Geppe N; Afonina E
    Reumatol Clin (Engl Ed); 2020; 16(5 Pt 1):356-358. PubMed ID: 29929808
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on the Systemic Treatment of Pediatric Localized Scleroderma.
    Foeldvari I
    Paediatr Drugs; 2019 Dec; 21(6):461-467. PubMed ID: 31667717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peristomal morphoea in a patient with systemic sclerosis.
    Jiang KW; Zagarella SS; Chan L; Harris A
    Australas J Dermatol; 2020 Nov; 61(4):e451-e452. PubMed ID: 32567671
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment in Juvenile Scleroderma.
    Zulian F; Tirelli F
    Curr Rheumatol Rep; 2020 Jun; 22(8):45. PubMed ID: 32591919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil for methotrexate-resistant juvenile localized scleroderma.
    Martini G; Saggioro L; Culpo R; Vittadello F; Meneghel A; Zulian F
    Rheumatology (Oxford); 2021 Mar; 60(3):1387-1391. PubMed ID: 32978631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Connective tissue nevus misdiagnosed as juvenile localized scleroderma.
    Tirelli F; Giraudo C; Soliani M; Calabrese F; Martini G; Gisondi P; Meneghel A; Zulian F
    Pediatr Rheumatol Online J; 2023 Oct; 21(1):125. PubMed ID: 37848914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview of Juvenile localized scleroderma and its management.
    Li SC; Zheng RJ
    World J Pediatr; 2020 Feb; 16(1):5-18. PubMed ID: 31786801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicohistopathological correlations in juvenile localized scleroderma: studies on a subset of children with hypopigmented juvenile localized scleroderma due to loss of epidermal melanocytes.
    Sung JJ; Chen TS; Gilliam AC; McCalmont TH; Gilliam AE
    J Am Acad Dermatol; 2011 Aug; 65(2):364-373. PubMed ID: 21570153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up.
    Furusawa A; Wakiguchi H; Okazaki F; Korenaga Y; Azuma Y; Yasudo H; Hasegawa S
    Int J Rheum Dis; 2022 Jan; 25(1):95-96. PubMed ID: 34866347
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systemic sclerosis (scleroderma) without scleroderma].
    Nadashkevych ON
    Lik Sprava; 2001; (3):93-4. PubMed ID: 11560041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital localized scleroderma.
    Zulian F; Vallongo C; de Oliveira SK; Punaro MG; Ros J; Mazur-Zielinska H; Galea P; Da Dalt L; Eichenfield LF
    J Pediatr; 2006 Aug; 149(2):248-51. PubMed ID: 16887444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphea and localized scleroderma in children.
    Vierra E; Cunningham BB
    Semin Cutan Med Surg; 1999 Sep; 18(3):210-25. PubMed ID: 10468041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scleroderma in Children and Adolescents: Localized Scleroderma and Systemic Sclerosis.
    Li SC
    Pediatr Clin North Am; 2018 Aug; 65(4):757-781. PubMed ID: 30031497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.